Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Blood Advances
|
May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
Gregory A Abel, Donnie Hebert, Cecilia Lee, et al.
Blood Advances
|
January 3, 2024
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
Onyee Chan, Najla Al Ali, Hammad Tashkandi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 20, 2024
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, et al.
Leukemia & Lymphoma
|
August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
Rami Komrokji, Megan Melody, Najla Al Ali, et al.
The Lancet. Haematology
|
March 29, 2023
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Guillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Leukemia Research
|
February 12, 2025
Characteristics and survival outcomes of patients with myelodysplastic syndromes with isolated 11q deletion
Kensuke Takaoka, Rami Komrokji, Kelly Chien, et al.
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
BMC Cancer
|
August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
David P Steensma, Medrdad Abedi, Rafael Bejar, et al.
British Journal of Haematology
|
December 12, 2023
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)
Ayalew Tefferi, Farah Fleti, Onyee Chan, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Blood Advances
|
May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
Gregory A Abel, Donnie Hebert, Cecilia Lee, et al.
Blood Advances
|
January 3, 2024
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
Onyee Chan, Najla Al Ali, Hammad Tashkandi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 20, 2024
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, et al.
Leukemia & Lymphoma
|
August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
Rami Komrokji, Megan Melody, Najla Al Ali, et al.
The Lancet. Haematology
|
March 29, 2023
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Guillermo Garcia-Manero, Aaron D Goldberg, Eric S Winer, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Leukemia Research
|
February 12, 2025
Characteristics and survival outcomes of patients with myelodysplastic syndromes with isolated 11q deletion
Kensuke Takaoka, Rami Komrokji, Kelly Chien, et al.
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
BMC Cancer
|
August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
David P Steensma, Medrdad Abedi, Rafael Bejar, et al.
British Journal of Haematology
|
December 12, 2023
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)
Ayalew Tefferi, Farah Fleti, Onyee Chan, et al.
Page
of 13